Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biogen Inc (NASDAQ:BIIB)

264.62
Delayed Data
As of May 05
 +1.50 / +0.57%
Today’s Change
242.07
Today|||52-Week Range
420.99
-13.62%
Year-to-Date

Today’s Trading

Previous close263.12
Today’s open263.58
Day’s range262.63 - 265.40
Volume1,105,910
Average volume (3 months)1,851,304
Market cap$58.0B
Dividend yield--
Data as of 05/05/2016

Growth & Valuation

Earnings growth (last year)+24.01%
Earnings growth (this year)+10.68%
Earnings growth (next 5 years)+9.50%
Revenue growth (last year)-3.87%
P/E ratio16.3
Price/Sales7.60
Price/Book6.17

Competitors

 Today’s
change
Today’s
% change
BXLTBaxalta Inc-0.03-0.07%
BAXBaxter International...+0.18+0.40%
JUNOJuno Therapeutics In...-0.53-1.38%
CTLTCatalent Inc-3.80-13.00%
Data as of 05/05/2016

Financials

Next reporting dateJuly 19, 2016
EPS forecast (this quarter)$4.66
Annual revenue (last year)$9.3B
Annual profit (last year)$3.5B
Net profit margin38.05%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
George A. Scangos
Chief Scientific Officer &
Executive VP
Spyridon Artavanis-Tsakonas
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers

Search for Jobs